Heart Test Laboratories, Inc. (HeartSciences) has filed a prospectus with the SEC for the resale of up to 34,684,859 shares of common stock by selling stockholders. The shares include 4,854,853 shares issued to Icahn School of Medicine at Mount Sinai (Mount Sinai) and additional shares issuable upon exercise of warrants. The company is also registering shares that may be sold to Lincoln Park Capital Fund, LLC (Lincoln Park) under a purchase agreement. HeartSciences will not receive proceeds from the selling stockholders, except from any cash exercise of warrants. Proceeds from sales to Lincoln Park will be used for working capital and general corporate purposes. The company's common stock and warrants are listed on the Nasdaq Capital Market under the symbols 'HSCS' and 'HSCSW,' respectively. The filing includes provisions that may deter hostile takeovers or changes in control or management.

Heart Test Laboratories, Inc. (HeartSciences) has filed a prospectus with the SEC for the resale of up to 34,684,859 shares of common stock by selling stockholders. The shares include 4,854,853 shares issued to Icahn School of Medicine at Mount Sinai (Mount Sinai) and additional shares issuable upon exercise of warrants. The company is also registering shares that may be sold to Lincoln Park Capital Fund, LLC (Lincoln Park) under a purchase agreement. HeartSciences will not receive proceeds from the selling stockholders, except from any cash exercise of warrants. Proceeds from sales to Lincoln Park will be used for working capital and general corporate purposes. The company's common stock and warrants are listed on the Nasdaq Capital Market under the symbols 'HSCS' and 'HSCSW,' respectively. The filing includes provisions that may deter hostile takeovers or changes in control or management.